Shareholder Alert: Ademi LLP investigates whether NuVasive, Inc. has obtained a Fair Price in its transaction with Globus Medical

Shareholder Alert: Ademi LLP investigates whether NuVasive, Inc. has obtained a Fair Price in its transaction with Globus Medical

PR Newswire

MILWAUKEE, Feb. 9, 2023

MILWAUKEE, Feb. 9, 2023 /PRNewswire/ -- Ademi LLP is investigating NuVasive (NASDAQ: NUVA) for possible breaches of fiduciary duty and other violations of law in its transaction with Globus Medical. 

Click here to learn how to join the action https://www.ademilaw.com/case/nuvasive-inc or call Guri Ademi toll-free at 866-264-3995.  There is no cost or obligation to you.

Ademi LLP alleges NuVasive's financial outlook and prospects are excellent and yet NuVasive shareholders will receive only 0.75 of a share of Globus Medical Class A common stock for each share of NuVasive common stock. Based on this exchange ratio, the implied share price for NuVasive would be $57.72, an equity value of $3.1 billion, based on Globus Medical's closing share price on February 8.  Following the close of the transaction, NuVasive shareholders will own approximately 28% of the combined company, and Globus Medical shareholders will own approximately 72%, on a fully diluted basis. The transaction agreement unreasonably limits competing bids for NuVasive by imposing a significant penalty if NuVasive accepts a superior bid. NuVasive insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of NuVasive's board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for NuVasive.

If you own NuVasive common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/nuvasive-inc.                       

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP                                                                                        
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-nuvasive-inc-has-obtained-a-fair-price-in-its-transaction-with-globus-medical-301743217.html

SOURCE Ademi LLP

Copyright CNW Group 2023